Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Androgen‐modulating agents for spinal bulbar muscular atrophy/Kennedy's disease

Esta versión no es la más reciente

ver la versión actual 04 enero 2022

Información

DOI:
https://doi.org/10.1002/14651858.CD012000Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 21 diciembre 2015see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Neuromuscular

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Fan Kee Hoo

    Correspondencia a: Neurology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

    [email protected]

  • Md. Shariful Hasan Sumon

    Neurology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

  • Hamidon Basri

    Neurology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

  • Wan Aliaa Wan Sulaiman

    Neurology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

  • Johnson Stanslas

    Pharmacology and Therapeutic Unit, Department of Medicine, Universiti Putra Malaysia, Serdang, Malaysia

  • Hasnur Zaman Hashim

    Neurology Department, International Islamic University Malaysia, Kuantan, Malaysia

  • Carolyn A Young

    The Walton Centre NHS Foundation Trust, Liverpool, UK

Contributions of authors

This work was conducted with the collaboration of all of the authors. FK and WA wrote the draft of the protocol. All authors participated in the preparation of the protocol and approved the final version.

Sources of support

Internal sources

  • None, Other.

External sources

  • None, Other.

Declarations of interest

Fan Kee Hoo, Md. Shariful Hasan Sumon, Hamidon Basri, Wan Aliaa Wan Sulaiman, Johnson Stanslas, and Hasnur Zaman Hashim: none to declare.

Carolyn Young has published on fatigue in various neurological conditions, including motor neuron disease, and advised a pharmaceutical company about a potential trial for fatigue in multiple sclerosis.

Acknowledgements

This project was supported by the National Institute for Health Research (NIHR) via Cochrane Infrastructure funding to the Cochrane Neuromuscular Disease Group. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service (NHS) or the Department of Health. The Cochrane Neuromuscular Disease Group also receives support from the Motor Neurone Disease Association and the Medical Research Council (MRC) Centre for Neuromuscular Disease.

The authors thank Ruth Brassington and the Cochrane Neuromuscular Disease Group for support in the preparation of this protocol. The methods are based on a template developed by the Cochrane Airways Group with minor adaptations by the Cochrane Neuromuscular Disease Group.

The authors acknowledge Angela Gunn for help in the development of the search strategy.

The authors acknowledge the support of the Malaysian Cochrane Network .

Version history

Published

Title

Stage

Authors

Version

2022 Jan 04

Androgen‐modulating agents for spinal bulbar muscular atrophy/Kennedy's disease

Protocol

Fan Kee Hoo, Md. Shariful Hasan Sumon, Hamidon Basri, Wan Aliaa Wan Sulaiman, Johnson Stanslas, Hasnur Zaman Hashim, Carolyn A Young

https://doi.org/10.1002/14651858.CD012000.pub2

2015 Dec 21

Androgen‐modulating agents for spinal bulbar muscular atrophy/Kennedy's disease

Protocol

Fan Kee Hoo, Md. Shariful Hasan Sumon, Hamidon Basri, Wan Aliaa Wan Sulaiman, Johnson Stanslas, Hasnur Zaman Hashim, Carolyn A Young

https://doi.org/10.1002/14651858.CD012000